{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:58:42Z","timestamp":1770231522724,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40520-019-01443-9","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T16:03:05Z","timestamp":1578067385000},"page":"1123-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Where are the keys to improve vaccine uptake in adults and elders in European countries?"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7792","authenticated-orcid":false,"given":"Jacques","family":"Gaillat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"1443_CR1","unstructured":"http:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/sage_assessment_reports\/en"},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"GBD 2016","year":"2018","unstructured":"GBD 2016 (2018) Lower respiratory infections collaborators, estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study. Lancet Infect Dis 18:1191\u20131210","journal-title":"Lancet Infect Dis"},{"key":"1443_CR3","unstructured":"Chan M, Fauci A, Lake A et al (2017) Reaching everyone, everywhere with life-saving vaccines. http:\/\/www.thelancet.com, vol 389, February 25, 2017"},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1016\/j.vaccine.2018.06.044","volume":"36","author":"S Sheikh","year":"2018","unstructured":"Sheikh S, Biundo E, Courcier S et al (2018) A report on the status of vaccination in Europe. Vaccine 36:4979\u20134992","journal-title":"Vaccine"},{"key":"1443_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0749-3797(03)00120-X","volume":"25","author":"GA Poland","year":"2003","unstructured":"Poland GA, Shefer AM, McCauley M et al (2003) Standards for adult immunization practices standards for adult immunization practices. Am J Prev Med 25:144\u2013150","journal-title":"Am J Prev Med"},{"key":"1443_CR6","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1016\/j.vaccine.2009.01.069","volume":"27","author":"GA Poland","year":"2009","unstructured":"Poland GA, Jacobson RM, Ovsyannikova A (2009) Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine\u00a0movement, and vaccinomics. Vaccine 27:3240\u20133244","journal-title":"Vaccine"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.amepre.2016.04.014","volume":"51","author":"BG Gelin","year":"2016","unstructured":"Gelin BG, Shen AK, Fish R et al (2016) The national adult immunization plan: strengthening adult immunization through coordinated action. Am J Prev Med 51:1079\u20131083. https:\/\/doi.org\/10.1016\/j.amepre.2016.04.014","journal-title":"Am J Prev Med"},{"key":"1443_CR8","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/j.1532-5415.2012.04048.x","volume":"60","author":"PL Gozalo","year":"2012","unstructured":"Gozalo PL, Pop-Vicas A, Feng Z et al (2012) The impact of influenza on the functional decline. J Am Geriatr Soc 60:1260\u20131267","journal-title":"J Am Geriatr Soc"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"1701794","DOI":"10.1183\/13993003.01794-2017","volume":"51","author":"C Warren-Gash","year":"2018","unstructured":"Warren-Gash C, Blackburn R, Whitaker H et al (2018) Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction or stroke : a self controlled case series analysis of national datasets from Scotland. Eur Respir J 51:1701794. https:\/\/doi.org\/10.1183\/13993003.01794-2017","journal-title":"Eur Respir J"},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.111.040766","volume":"125","author":"VF Corrales-Medina","year":"2012","unstructured":"Corrales-Medina VF, Musher DM, Wells GA et al (2012) Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Traffic 125:773\u2013781. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.040766","journal-title":"Traffic"},{"key":"1443_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12879-017-2278-z","volume":"17","author":"F Marra","year":"2017","unstructured":"Marra F, Ruckenstein J, Richardson A (2017) A meta-analysis of stroke risk following herpes zoster infection. BMC Infect Dis 17:198. https:\/\/doi.org\/10.1186\/s12879-017-2278-z","journal-title":"BMC Infect Dis"},{"key":"1443_CR12","first-page":"575","volume":"139","author":"D Modin","year":"2019","unstructured":"Modin D, J\u00f8rgensen ME, Gislason G et al (2019) Solomon SD4, Torp-Pedersen C1,2, biering-S\u00f8rensen T1 influenza vaccine in heart Failure. Traffic. 139:575\u2013586","journal-title":"Traffic."},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.4161\/21645515.2014.982998","volume":"11","author":"L Tan","year":"2014","unstructured":"Tan L (2014) Adult vaccination now is the time to realize an unfulfilled potential. Hum Vaccines Immunother 11:2158\u20132166","journal-title":"Hum Vaccines Immunother"},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14745\/ccdr.v41is3a01","volume":"41","author":"I Gemmil","year":"2019","unstructured":"Gemmil I (2019) Vaccines for adults: the time has come. Can Commun Dis Rep 41:2\u20135","journal-title":"Can Commun Dis Rep"},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2017.1333425","volume":"16","author":"T Villafana","year":"2017","unstructured":"Villafana T, Falloon J, Griffin MP et al (2017) Passive and active immunization against respiratory syncytial virus for the young and old. Expert Rev Vaccines 16:1\u201313. https:\/\/doi.org\/10.1080\/14760584.2017.1333425","journal-title":"Expert Rev Vaccines"},{"key":"1443_CR16","unstructured":"Council of the European Communities (2009) Proposal for a council recommendation on seasonal influenza vaccination 2009 [cited 2016 May 27]. http:\/\/ec.europa.eu\/health\/ph_threats\/com\/Influenza\/docs\/seasonflu_rec2009_en.pdf"},{"key":"1443_CR17","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/1469-0691.12315","volume":"19","author":"H Nohynek","year":"2013","unstructured":"Nohynek H, Wichmann O, Dancona F et al (2013) National advisory groups and their role in immunization policy-making processes in European countries. Microbiol Infect 19:1096\u20131105","journal-title":"Microbiol Infect"},{"key":"1443_CR18","unstructured":"Mereckiene J. Seasonal influenza vaccination and antiviral use in Europe. Technical report. ECDC . http:\/\/www.ecdc.europa.eu"},{"key":"1443_CR19","unstructured":"Public Health England, Health Protection Report Volume 11 Number 23 30 June 2017. https:\/\/www.gov.uk\/government\/publications\/health-protection-report-volume-11-2017"},{"key":"1443_CR20","doi-asserted-by":"crossref","unstructured":"Falkenhorst G, Remschmidt C, Harder T et al (2016) Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany. Bundesgesundheitsbl 59:1623\u20131657. https:\/\/doi.org\/10.1007\/s00103-016-2466-9","DOI":"10.1007\/s00103-016-2466-9"},{"key":"1443_CR21","unstructured":"Haut conseil de sant\u00e9 publique Avis relatif aux recommandations vaccinales contre les infections \u00e0 pneumocoque pour les adultes 10 mars 2017. http:\/\/www.hcsp.fr"},{"key":"1443_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","volume":"15","author":"PA Waight","year":"2015","unstructured":"Waight PA, Andrews NJ, Ladhani SN et al (2015) Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4\u00a0years after its introduction: an observational cohort study. Lancet Infect Dis 15:535\u2013543","journal-title":"Lancet Infect Dis"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1469-0691.2005.01282.x","volume":"11","author":"RR Reinert","year":"2005","unstructured":"Reinert RR, Haupts S, van der Linden M et al (2005) Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001\u20132003. Clin Microbiol Infect 11:985\u2013991","journal-title":"Clin Microbiol Infect"},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","volume":"33","author":"A Lepoutre","year":"2015","unstructured":"Lepoutre A, Varon E, Georges S et al (2015) The microbiologists of the Epibac, the ORP networks, impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001\u20132012. Vaccine 33:359\u2013366. https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.011","journal-title":"Vaccine"},{"key":"1443_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.medmal.2015.10.004","volume":"45","author":"P Casez","year":"2015","unstructured":"Casez P, Fauconnier J, Jorgensen L et al (2015) Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005\u20132010). Med Mal Inf 45:446\u2013455","journal-title":"Med Mal Inf"},{"key":"1443_CR26","unstructured":"Health Protection Report Volume 11 Number 23\u201330 June 2017, Rodrigo. Eur Respir J 45:1632\u20131641"},{"key":"1443_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4161\/hv.26986","volume":"10","author":"T Rieck","year":"2014","unstructured":"Rieck T, Feig M, Eckmanns T et al (2014) Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Human Vaccines Immunother 10:476\u2013484","journal-title":"Human Vaccines Immunother"},{"key":"1443_CR28","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ (2014) Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4:e004833. https:\/\/doi.org\/10.1136\/bmjopen-2014-004833","journal-title":"BMJ Open"},{"key":"1443_CR29","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","volume":"30","author":"AJ van Hoek","year":"2012","unstructured":"van Hoek AJ, Melegaro A, Gay N et al (2012) Edmunds WJ The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 30:1225\u20131234","journal-title":"Vaccine"},{"key":"1443_CR30","unstructured":"Herida M, Belchior E, Le Strat Y et al (2013) Evaluation medico-\u00e9conomique de la vaccination contre le zona en France. CTV. http:\/\/www.sante.gouv.fr"},{"key":"1443_CR31","unstructured":"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/729910\/hpr2718_shngls-vc.pdf"},{"key":"1443_CR32","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00103-017-2618-6","volume":"60","author":"A Siedler","year":"2017","unstructured":"Siedler A, Koch J, Ultsch B et al (2017) Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany. Bundesgesundheitsbl 60:1162\u20131179. https:\/\/doi.org\/10.1007\/s00103-017-2618-6","journal-title":"Bundesgesundheitsbl"},{"key":"1443_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1377\/hlthaff.2015.0420","volume":"35","author":"DB Ridely","year":"2016","unstructured":"Ridely DB, Bei X, Liebman EB (2016) No shot: US vaccine prices and shortages. Health Aff (millwood) 35:235\u2013241. https:\/\/doi.org\/10.1377\/hlthaff.2015.0420","journal-title":"Health Aff (millwood)"},{"key":"1443_CR34","unstructured":"Mooney C (2010) Do scientists understand the public? American Academy of Arts and Sciences, Cambridge. https:\/\/www.amacad.org\/multimedia\/pdfs\/publications\/researchpapersmonographs\/scientistsUnderstand.pdf"},{"key":"1443_CR35","doi-asserted-by":"crossref","unstructured":"Douglas J (2009). Opel et al., \u201cSocial marketing as a strategy to increase immunization rates,\u201d. Arch Pediatr Adolesc Med 163: 432\u2013437. https:\/\/doi.org\/10.1001\/archpediatrics.2009.42","DOI":"10.1001\/archpediatrics.2009.42"},{"issue":"3","key":"1443_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4161\/hv.18629","volume":"8","author":"P Blank","year":"2012","unstructured":"Blank P, Schwenkglenks M, Szucs TD (2012) The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother 8:328\u2013335","journal-title":"Hum Vaccin Immunother"},{"key":"1443_CR37","unstructured":"National Flu immunisation programme for 2019 to 2020. Ref: PHE publications gateway number 2018767 PDF, 467\u00a0KB, 30. http:\/\/www.gov.uk\/government\/publications\/national-flu-immunisation-programme-plan"},{"key":"1443_CR38","unstructured":"Green Book chapter 28a Shingles (herpes zoster) https:\/\/www.gov.uk\/government\/publications\/shingles-herpes-zoster-the-green-book-chapter-28a"},{"key":"1443_CR39","unstructured":"ECDC, Catalogue of intervention addressing vaccine hesitancy. Technical report. http:\/\/www.ecdc.europa.eu"},{"key":"1443_CR40","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1016\/j.vaccine.2017.09.046","volume":"35","author":"LE Smith","year":"2017","unstructured":"Smith LE, Aml\u00f4t R, Weinman J et al (2017) A systematic review of factors affecting vaccine uptake in young children. Vaccine 35:6059\u20136069. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.046","journal-title":"Vaccine"},{"key":"1443_CR41","doi-asserted-by":"crossref","unstructured":"Stefanoff P, Mamelund SE, Robinson M et al (2010) VACSATC working group on standardization of attitudinal studies in Europe. Tracking parental attitudes on vaccination across European countries: the Vaccine safety, attitudes, training and communication project (VACSATC). Vaccine 28:5731\u20135737. http:\/\/dx.doi.org\/10.1016\/j.vaccine.2010.06.009","DOI":"10.1016\/j.vaccine.2010.06.009"},{"key":"1443_CR42","doi-asserted-by":"publisher","unstructured":"Kassianos G, Blank P, Falup-Pecurariu O et al (2016) Influenza vaccination: key factors for general practitioners in Europe\u2014a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands drugs in context 5:212293. https:\/\/doi.org\/10.7573\/dic.212293","DOI":"10.7573\/dic.212293"},{"key":"1443_CR43","doi-asserted-by":"crossref","unstructured":"Ammi M, Fortier G (2017) The influence of welfare systems on pay-for-performance programs for general practitioners: a critical review. Soc Sci Med 178:157e166","DOI":"10.1016\/j.socscimed.2017.02.019"},{"key":"1443_CR44","doi-asserted-by":"publisher","unstructured":"Isenor JE, O\u2019Reilly BA, Bowles SK (2018) Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006\u20132016. BMC Public Health 18:787. https:\/\/doi.org\/10.1186\/s12889-018-5697-x","DOI":"10.1186\/s12889-018-5697-x"},{"key":"1443_CR45","unstructured":"JORF n 0097 du 25 avril 2019 texte n\u00b0 9 D\u00e9cret n\u00b0 2019-357 du 23 avril 2019 relatif \u00e0 la vaccination par les pharmaciens d\u2019officine NOR: SSAP1905311DELI: https:\/\/www.legifrance.gouv.fr\/eli\/decret\/2019\/4\/23\/SSAP1905311D\/jo\/texte"},{"key":"1443_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3122\/jabfm.18.1.20","volume":"18","author":"MP Nowalk","year":"2005","unstructured":"Nowalk MP, Zimmerman RK, Cleary SM et al (2005) Missed opportunities to vaccinate older adults in primary care. J Am Board Fam Pract 18:20\u201327","journal-title":"J Am Board Fam Pract"},{"key":"1443_CR47","unstructured":"https:\/\/www.who.int\/emergencies\/ten-threats-to-global-health-in-2019"},{"key":"1443_CR48","unstructured":"http:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf"},{"key":"1443_CR49","doi-asserted-by":"crossref","unstructured":"Bedford H, Attwell K, Danchin M et al (2018) Vaccine hesitancy, refusal and access barriers: THE need for clarity in terminology. Vaccine 36:6556\u20136558","DOI":"10.1016\/j.vaccine.2017.08.004"},{"key":"1443_CR50","unstructured":"http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0004\/329647\/Vaccines-and-trust.PDF?ua=1"},{"key":"1443_CR51","doi-asserted-by":"publisher","unstructured":"Larson HJ, de Figueiredo A, Xiahong Z et al (2016) The state of vaccine confidence 2016: global insights through a 67-country survey. BioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.042","DOI":"10.1016\/j.ebiom.2016.08.042"},{"key":"1443_CR52","unstructured":"https:\/\/www.vaccineconfidence.org\/research\/the-state-of-vaccine-confidence-in-the-eu-2018\/"},{"key":"1443_CR53","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"NE MacDonald","year":"2015","unstructured":"MacDonald NE (2015) Vaccine hesitancy: definition, scope and determinants. Vaccine 33:4161\u20134164","journal-title":"Vaccine"},{"key":"1443_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1586\/14760584.2015.964212","volume":"14","author":"E Dub\u00e9","year":"2015","unstructured":"Dub\u00e9 E, Vivion M, MacDonald NE (2015) Vaccine hesitancy, vaccine refusal ant the anti-vaccine movement: influence, impact, implications. Expert Rev Vaccines 14:99\u2013117","journal-title":"Expert Rev Vaccines"},{"key":"1443_CR55","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1016\/j.vaccine.2011.11.112","volume":"30","author":"A Kata","year":"2012","unstructured":"Kata A (2012) Anti-vaccine activists, Web 2.0, and the postmodern paradigm\u2014an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine 30:3778\u20133789","journal-title":"Vaccine"},{"key":"1443_CR56","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1016\/j.vaccine.2015.04.041","volume":"33","author":"E Dub\u00e9","year":"2015","unstructured":"Dub\u00e9 E, Gagnon D, MacDonald NE (2015) The SAGE working group on vaccine hesitancy. Vaccine 33:4191\u20134203","journal-title":"Vaccine"},{"key":"1443_CR57","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1016\/j.vaccine.2017.10.049","volume":"36","author":"A Gagneur","year":"2018","unstructured":"Gagneur A, Gosselin V, Dub\u00e9 E (2018) Motivational interviewing: a promising tool to address vaccine hesitancy. Vaccine 36:6553\u20136555","journal-title":"Vaccine"},{"key":"1443_CR58","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1016\/j.vaccine.2017.09.064","volume":"36","author":"J Parrish-Sprowl","year":"2018","unstructured":"Parrish-Sprowl J (2018) Vaccine hesitancy communication: what counts as evidence? Vaccine 36:6529\u20136530","journal-title":"Vaccine"},{"key":"1443_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/15412550802093108","volume-title":"Motivational interviewing in health care. helping patients change behavior","author":"S Rollnick","year":"2008","unstructured":"Rollnick S, Miller WR, Butler CC (2008) Motivational interviewing in health care. helping patients change behavior. The Guilford Press, New York London"},{"key":"1443_CR60","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.vaccine.2015.11.065","volume":"34","author":"A Thomson","year":"2016","unstructured":"Thomson A, Robinson K, Vall\u00e9e-Tourangeau G (2016) The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine 34:1018\u20131024","journal-title":"Vaccine"},{"key":"1443_CR61","first-page":"2","volume":"17","author":"B Pebody","year":"2012","unstructured":"Pebody B (2012) Vaccine registers Experience from Europe and elsewhere. Eurosurv 17:2\u20134","journal-title":"Eurosurv"},{"key":"1443_CR62","first-page":"7","volume":"1","author":"KA Shen","year":"2018","unstructured":"Shen KA, Williams WW, O\u2019Halloran A et al (2018) Promoting adult immunization using population-based data for a composite measure. Am J Prev Med 1:7","journal-title":"Am J Prev Med"},{"key":"1443_CR63","unstructured":"Haut Conseil de Sant\u00e9 Publique Avis 2007 sur la vaccination BCG. http:\/\/www.hcsp.fr"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-019-01443-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:35:36Z","timestamp":1619674536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-019-01443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1007\/s40520-019-01443-9","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"11 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JGaillat received fees as consultant for advisory boards or as speaker for symposia for MSD, Sanofi Pasteur, Pfizer, GSK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}